N. Chandababu Naidu, Prime Minister of Andhra Pradesh, launching lumpy skin diseases against organic pivaxin. Raches she, development director of Bharat Biotech, is on her left.
Andhra Pradesh Prime Minister, N Chandababu, has launched the first vaccine on the world’s diva market for lump skin disease (LSD), which caused a ravage in the country by causing deaths or more than two LAKH of cattle. Developed by Biovet, a subsidiary or biotechnology of Bharat, Bioolumpivaxin addresses a serious challenge facing the animal breeding sector, offering great relief to farmers.
Firmer skin disease (LSD) is a cross -border animal disease that has gained significant attention on India due to its serious impact on livestock and dairy industry. The disease is characterized by the development of skin nodules throughout the body, fever, swollen lymph nodes, decreased milk performance and difficulty in movement.
Biolumpivaxin is a new indigenous vaccine of attennted markers developed with the Research-Research-Investigation-Research-Investigation-Research-Research-Research Center for Research Research Research of the Agriculture Research of LSD/RANCHI/2019 (ICAR-NRCE), Hisar, in collaboration, in collaboration, in collaboration, in collaboration, in collaboration,
Appreciating biovet to develop the vaccine made in India, Naidu requested measures to an effective vaccine distribution. “In addition to helping the State achieve the 20 percent objective in the livestock, it will promote long -term sustainability of the dairy industry,” he said.
“The Diva Marker LSD vaccine is an important step to eradicate the LSD,” said Krishna, founder of Biovet and executive president or biotechnology of Bharat.
“Livestock, Alongsisid Our Human Resources, representatives One of the Nation’s Greatest Assets, Contribution Significantly to Our Economy and Overall Prsperity. We We Advance, and Advance, and Advance, and Advance, and Advance, and Advance, and Advance, and Advance, and Advance, and Advance, and Advance.
“The quality, safety and efficacy of Biolumpivaxin® have been widely tested at the India-Research Institute of Agricultural Research (IVRI) of the Indian Agriculture Council (IVRI) and the Research-Research Center for Research for the Agricultural Research of India on Equines (ICAR-NRCE) that guarantees that it complies with the highest world standards,” he said.
Vaccination has proven to be the most effective strategy to control LSD virus, particularly with homologous vaccines.
Biovet said it can produce 500 million doses of the vaccine of its production facilities in Bangalore, ensuring sustainable supplies.
According to the National Statistics of the Animal Breeding Department, there have been two main outbreaks of LSD in India, the first in 2019 and the second in 2022. Duration over two Lakh won lost the producers more than more cattle.
When a cattle contract lsd, it suffers from high fever and painful skin nodules that can be a production of fatal and contaminated milk. The infection reduces the performance of the milk, which represents a serious threat to large -scale dairy and interrupting the broader milk supply chain.
Duration The outbreak of LSD 2022 In India, Morbida rates reached up to 80 percent with fatality rates of cases such as high axis of 67 percent, in all states such as Gujarat, Rajasthan, Maharashtra, Uttar Pradesh, Punjabir.
This caused an estimated economic loss or in ₹ 18.337.76 million rupees and a 26 percent decrease in milk production, significantly damaging the dairy industry and the rural economy.
In India, LSD has become a great threat to dairy products, which affected millions of small -scale marginal farmers.
Posted on May 14, 2025
